MAR 24, 2019 3:51 PM PDT

Synthetic Oxytocin for Obesity Treatment

WRITTEN BY: Nouran Amin

According to recent research, the hormone oxytocin reduced the communication in different regions of the brain involved in the cognitive, sensory and emotional processing of food cues that are demonstrated in obese individuals when they look at high-calorie foods. The research may result in the production of a new drug—a synthetic nasal formulation of oxytocin for the treatment of obesity.

Oxytocin is a naturally occurring hormone known for its role in social bonding, childbirth and breastfeeding, it’s also critical for controlling food intake and weight. Previous research suggested that an oxytocin nasal spray, not yet approved in the United States, targeted brain pathways implicated in eating behavior which decreased food consumption in men.

"Knowing how the drug exerts its effects is a critical step toward establishing oxytocin as a drug treatment for overeating and obesity," said the study's lead investigator, Liya Kerem, M.D., M.Sc., a pediatric endocrinology fellow at MassGeneral Hospital for Children and a research fellow at Massachusetts General Hospital in Boston, Mass. "This study is exciting because it shows that oxytocin modulates the pathways in the brain specifically during their responses to highly palatable, rewarding foods."

The study found that in comparison to a placebo, oxytocin weakened the functional connectivity involved in the effective coordination between neural systems in brain responding to a task. No side-effects were reported.

"Individuals with obesity, compared to lean people, have abnormally hyperactivated brain reward areas when viewing high-calorie food images, even when they are full, suggesting an explanation for the observed behavior of overeating and a potential target for treatment with medications such as oxytocin," Kerem said.

Source: medicalxpress.com

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Psychedelic DMT Creates Vivid Waking Dream State in Brain
In a new study, scientists at Imperial College London investigated how powerful psychedelic dimethyltryptamine (DMT) alters the brain’s electrical ac...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Single Dose Ketamine Could Rewire Alcohol, Drug Dependance
Presentation by Tobias Stephenson about previous research exploring ketamine as an addiction treatment.    Researchers at University College Lond...
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
Drug Targets Against The Nipah Virus
The Nipah virus, first identified in 1998 and is transmitted from pigs and bats, has resulted in a high mortality rate killing more than half of all infect...
DEC 21, 2019
Drug Discovery & Development
DEC 21, 2019
Magic Mushrooms Pass First Clinical Trial Against Depression
With the efficacy of selective serotonin reuptake inhibitors such as Prozac increasingly coming under question, the search for new pharmaceutical treatment...
DEC 22, 2019
Genetics & Genomics
DEC 22, 2019
New Gene Therapy Uses Exosomes to Reverse Disease
Researchers at Ohio State University have developed a new gene therapy that makes use of exosomes, fluid sacs released in cells, to carry therapeutic tools...
FEB 04, 2020
Cancer
FEB 04, 2020
The role of SRR in colorectal cancer
Researchers from Osaka University have recently discovered a new function of the multifunctional enzyme entitled serine racemase (SRR). According to the te...
Loading Comments...